| Product Code: ETC6188169 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pharmacogenetic testing market in Australia is advancing as personalized medicine gains traction. By analyzing genetic variations that influence drug response, these tests help tailor medications to individual patients, improving efficacy and safety. The sector is supported by increasing clinical adoption, research funding, and regulatory guidance on test validity.
This market is trending upward due to increasing awareness of personalized medicine. In Australia, pharmacogenetic testing is being more widely adopted to tailor treatments based on an individual`s genetic profile. The healthcare system is gradually incorporating genetic screening into clinical practice, particularly for conditions like cancer and cardiovascular diseases.
Despite its potential, this market faces challenges due to limited awareness and education among healthcare providers. Regulatory ambiguity and lack of standardization in test interpretation affect trust and reliability. High testing costs and insufficient insurance coverage also act as significant barriers.
Pharmacogenetic testing is gaining ground under the Precision Medicine Initiative in Australia. The government supports genomics research and diagnostics infrastructure through programs like Genomics Health Futures Mission, encouraging investment in testing services. Foreign biotech firms and local startups receive co-investment opportunities via the Medical Research Future Fund (MRFF).
The Australia government, through the National Health and Medical Research Council (NHMRC), supports the integration of genetic testing into clinical practice. Policies emphasize ethical guidelines, data privacy, and informed consent in genetic testing. Funding and support for precision medicine initiatives further enable the growth of pharmacogenetic testing in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmacogenetic Testing Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Australia Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Australia Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare professionals about the benefits of pharmacogenetic testing |
4.2.2 Growing demand for personalized medicine and precision healthcare |
4.2.3 Favorable government initiatives promoting adoption of pharmacogenetic testing |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for pharmacogenetic tests |
4.3.3 Lack of standardized guidelines for pharmacogenetic testing |
5 Australia Pharmacogenetic Testing Market Trends |
6 Australia Pharmacogenetic Testing Market, By Types |
6.1 Australia Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Australia Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Australia Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Australia Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Australia Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Australia Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Australia Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Australia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Australia Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Australia Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Australia Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Australia Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Australia Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Australia Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Australia Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Australia Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Australia Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Australia Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Australia Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Australia Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Australia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Australia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Australia Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Australia Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Australia Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Australia Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Australia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Australia Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Australia Pharmacogenetic Testing Market Export to Major Countries |
7.2 Australia Pharmacogenetic Testing Market Imports from Major Countries |
8 Australia Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare providers offering pharmacogenetic testing services |
8.2 Adoption rate of pharmacogenetic testing by major healthcare institutions |
8.3 Number of research studies and publications supporting the efficacy of pharmacogenetic testing |
9 Australia Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Australia Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Australia Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Australia Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Australia Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Australia Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Australia Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Australia Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |